deleder2k
Senior Member
- Messages
- 1,129
Of course!
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
@deleder2k I really don't know how to thank you enough for keeping us informed and updated, you're our star of the north .The open phase 2 study is being proofread before it is sent in for publishing We're getting there. I guess it will take a few weeks before it will get published though.
Tx deleder, you are very good informant
Do you mean the rtx phase 2 study? Not to be confused with the pilot study of the new drug?
@deleder2k I really don't know how to thank you enough for keeping us informed and updated, you're our star of the north .
Yes, the phase 2 study. To my knowledge the name and the project description of the drug will be released on the Regional Committees for Medical and Health Research Ethics website. I am checking their site a few times daily.. dah.
Thanks for checking
I think you have misunderstood. The stars are Øystein Fluge, Olav Mella, The Cancer Department at Haukeland University Hospital, @Jonathan Edwards + the rest of the UK Rituximab trial team
I think you have misunderstood. The stars are Øystein Fluge, Olav Mella, The Cancer Department at Haukeland University Hospital, @Jonathan Edwards + the rest of the UK Rituximab trial team
Hm, I guess someone knows more about it. I really have no clue, but when speaking to one of the doctors at Haukeland I was under the impression that this was something "new". I hope we know the name in a couple or weeks. My patience is running out!